This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Sep 1;140(9):938-939.

doi: 10.1182/blood.2022017346.

NETs in sickle cell disease, quo vadis?

Lidiane S Torres¹, Andrés Hidalgo²

Affiliations

PMID: 36048478
DOI: 10.1182/blood.2022017346

Free article

Editorial

NETs in sickle cell disease, quo vadis?

Lidiane S Torres et al. Blood. 2022.

Free article

. 2022 Sep 1;140(9):938-939.

doi: 10.1182/blood.2022017346.

Authors

Lidiane S Torres¹, Andrés Hidalgo²

Affiliations

¹ Albert Einstein College of Medicine; and.
² Yale University School of Medicine.

PMID: 36048478
DOI: 10.1182/blood.2022017346

No abstract available

PubMed Disclaimer

Comment on

Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease.
Vats R, Kaminski TW, Brzoska T, Leech JA, Tutuncuoglu E, Katoch O, Jonassaint J, Tejero J, Novelli EM, Pradhan-Sundd T, Gladwin MT, Sundd P. Vats R, et al. Blood. 2022 Sep 1;140(9):1020-1037. doi: 10.1182/blood.2021014552. Blood. 2022. PMID: 35737916 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science